Alzheimer Disease in 2020
Open Access
- 1 November 2012
- journal article
- review article
- Published by Cold Spring Harbor Laboratory in Cold Spring Harbor Perspectives in Medicine
- Vol. 2 (11) , a011585
Abstract
Remarkable advances in unraveling the biological underpinnings of Alzheimer disease (AD) have occurred during the last 25 years. Despite this, we have made only the smallest of dents in the development of truly disease-modifying treatments. What will change over the next 10 years? While the answer is not clear, we make several predictions on the state of the field in 2020, based on the rich knowledge described in the other contributions in this collection. As such, our predictions represent some of the principal unresolved questions that we believe deserve special investigative attention in the coming decade.Keywords
This publication has 3 references indexed in Scilit:
- Treatment Strategies Targeting Amyloid -ProteinCold Spring Harbor Perspectives in Medicine, 2012
- Symptomatic and Nonamyloid/Tau Based Pharmacologic Treatment for Alzheimer DiseaseCold Spring Harbor Perspectives in Medicine, 2011
- Developing Therapeutic Approaches to Tau, Selected Kinases, and Related Neuronal Protein TargetsCold Spring Harbor Perspectives in Medicine, 2011